期刊文献+

三种细胞因子与造血干细胞移植后GVHD的相关研究 被引量:2

Study on Relation with 3 Kinds of Cytokines in Leukemia Patients with Post Allo-HSCT GVHD
下载PDF
导出
摘要 目的探讨细胞因子TNF-α,IL-4和TGF-α在白血病异基因造血干细胞移植(allogeneic hematopoietic stem celltransplantation,Allo-HSCT)后的变化与发生移植物抗宿主病(GVHD)及轻重程度的关系。方法用放射免疫分析法检测了42例白血病Allo-HSCT患者、30例正常健康人血清TNF-α,IL-4和TGF-α水平,对移植后发生或未发生急性或慢性GVHD及发生的轻重程度进行了比较。结果急、慢性GVHD组较未发生急、慢性GVHD组患者的血清TNF-α,IL-4,TGF-α水平均升高,与正常对照组比P<0.05(除急性GVHD-组的TGF-α及慢性GVHD-组的TNF-α浓度低外);急、慢性GVHD组与未发生急、慢性GVHD组比较,血清TNF-α,IL-4及TGF-α水平均差异显著(P<0.05);发生急或慢性GVHD重度组较轻度组的TNF-α,IL-4及TGF-α水平高,差异显著,P<0.01或<0.05(除慢性GVHD时IL-4差异不显著)。结论Allo-HSCT术后动态监测TNF-α,IL-4和TGF-α水平变化有助于对发生急慢性GVHD的可能性提供另一种检测方法,并对判断GVHD轻重程度有一定的临床意义。 Objective To study alterations in the serum levels of TNF-α,IL-4 and TGF-α with allogeneic hematopoietic stem cell transplantation,Allo-HSCT and their relationship with clinical course,the seriousness and mildness of graf vevsus host disease(GVHD). Methods Radio-immuno-assays of serum TNF-α,IL-4 and TGF-α were applied to analyse 42 cases of leukemia patients having undergone Allo-HSCT and 30 normal controls. Comparison of serum levels of the cytokines was made between patients with aGVHD and those without aGVHD,and between those with cGVHD and those without aGVHD. Comparison of the seriousness and mildness of GVHD was also made. Results The serum levels of TNF-α,IL-4 and TGF-α in the patients with aGVHD,in those with cGVHD and in those without both aGVHD and cGVHD were higher than the serum levels of the above eytokines in the normal controls(P〈0. 05). Except the low levels of TNF-α in the patients without aGVHD and TGF-α in the patients without cGVHD, comparison between the patients with aGVHD or cGVHD and those without aGVHD or cGVHD showed that the serum levels of TNF-α,IL-4 and TGF-α were all higher (P〈0.05)than the normal controls. Conclusion Dynamically monitoring the serum levels of TNF-α,IL-4 and TGF-α post Allo -HSCT is another method of predicting the possible occurrence of aGVHD or cGVHD as well as the seriousness and mildness of GVHD and it contributes considerably to the clinical course.
出处 《现代检验医学杂志》 CAS 2007年第5期4-7,共4页 Journal of Modern Laboratory Medicine
关键词 细胞因子 造血干细胞移植 移植物抗宿主病 cytokine Allo-HSCT GVHD
  • 相关文献

参考文献11

  • 1Champlin R,Khouri I,Kormblau S,et al.Reinventing bone marrow transplantation:reducing toxicity using nonmyeloblastive,preparative regimens and induction of graft versus-malignancy[J].Curr Opin Oncol,1999,11:87-95.
  • 2Hansen J,Gooley TA,Matin PJ,et al.Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia[J].N Engl J Med,1998,338(14):962-968.
  • 3Burnett AK,Wheatley K,Goldstone AH,et al.The value of allogeneic bone marrow transplantation in patients with acute myeloid leukemia at differing risk of relapse:results of the UK MRC AML 10 trial[J].Br J Haematol,2002,118:385-400.
  • 4Pui CH,Evans WE.Treatment of acute lymphoblastic leukemia[J].N Engl J Med,2006,354(2):166-178.
  • 5Schots R,Kaufman L,Van-Riet I,et al.Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation[J].Leukemia,2003,17 (6):1150-1156.
  • 6Roy J,Blazar BR,Ochs L,et al.The tissue expression of cytokines in human acute cutaneous graft-versus-host disease[J].Transplantation,1995,60:343-348.
  • 7Hall BM.Mechanisms of induction of tolerance to organ allografts[J].Crit Rev Immunol,2000,20 (4):267-324.
  • 8Ferrara JL.The cytokine modulation of acute graft-versus-host disease[J].Bone Marrow Transplant,1998,21 (suppl3):13-15.
  • 9胡洪慧,王凤山,凌沛学.白细胞介素-4的研究进展[J].中国药学杂志,2005,40(10):721-725. 被引量:29
  • 10Le Moine A,Flamand V,Demoor FX,et al.Critical roles for IL-4,IL-5 and eosinophils in chronic skin allograft rejection[J].J Clin Invest,1999,103:1659-1667.

二级参考文献50

  • 1刘平.肿瘤坏死因子在恶性血液病中的作用[J].国外医学(输血及血液学分册),1994,17(4):206-208. 被引量:7
  • 2Spatafore M, Gjomarkai M, Merendine A, et al. Antitumor activity of monouclear phagocytes: role of tumor necrosis factor alpha. Respiration. 1992, 59(suppl):47.
  • 3Ramsdell JS. Transforming growth factor-alpha and beta are potent and effective inhibitors of GH4 pituitary tumor cell proliferation. Endocrinology. 1991, 128(4):1981.
  • 4Kato H, Kinoshita T, Suzaki S, et al. Elevated serum interleukin-6 is derived from reoplastic lymphoid cells in patients with B-cell non Hodgkin's lymphoma; correlation with extent of IL-6 expression and serum concentration. Br J Haematol. 1996, 92:1014.
  • 5Frrajoli A, Keating MJ, Manshouri T, et al. The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia. Blood. 2002, 100(4):1215.
  • 6Warzocha K, Salles G, Bienvenu J, et al. Prognostic significance of TNF alpha and its P55 soluble receptor in malignant lymphomas. Leukemia. 1997, 11(suppl 3):S441.
  • 7沈志祥.血液病新进展[M].北京:人民卫生出版社,2000.239.
  • 8Kim SH,Kim S,Evans CH,et al.Effective treatment of established murine collagen-induced arthritis by systemic administration of dentritic cells genetically modified to express IL-4 [J].J Immunol, 2001,166(5):3499.
  • 9Fernandez M,Porosnicu M,Markovic D,et al.Genetically engineered vesicular stomatitis virus in gene therapy:application for treatment of maglinant disease[J].J Virol,2002,76(2):895.
  • 10Broberg EK,Salml AA,Hukkanen V.IL-4 is the key regulator in herpes simplex virus-based gene therapy of BALB/c experimental autoimmune encephalomyelitis[J].Neurosci Lett,2004,364:173.

共引文献29

同被引文献8

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部